Arbutus Biopharma Corpora...

NASDAQ: ABUS · Real-Time Price · USD
3.33
-0.04 (-1.19%)
At close: Aug 15, 2025, 3:59 PM
3.37
1.01%
After-hours: Aug 15, 2025, 05:47 PM EDT

Arbutus Biopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
15.42M 6.4M 6.17M 6.74M 10.06M 12.99M 18.14M 22.24M 23.54M 33.13M 39.02M 35.98M 33.37M 21.46M 10.99M 10.17M 8.35M 7.54M
Cost of Revenue
9.3M 9.65M 16.09M 16.12M 16.49M 16.47M 1.4M 1.35M 1.33M 1.37M 1.43M 1.55M 17.91M 33.33M 46.72M 60.83M 56.18M 50.85M
Gross Profit
6.11M -3.25M 5.13M 5.67M 8.62M 11.56M 16.74M 20.89M 22.21M 31.76M 37.59M 34.43M 15.46M -11.87M -35.73M -50.66M -47.83M -43.31M
Operating Income
-68.12M -91.4M -75.93M -82.52M -82.63M -79.65M -77.88M -79.92M -76.17M -71.89M -65.46M -63.69M -64.29M -68.82M -73.52M -69.03M -65.84M -60.34M
Interest Income
5.45M 6.24M 6.58M 6.59M 6.33M 5.96M 5.69M 5.17M 4.37M 3.3M 2.19M 1.28M 612K 247K 127K 193K 266K 435K
Pretax Income
-54.25M -76.57M -69.92M -76.7M -77.09M -74.39M -72.85M -75.47M -72.93M -70.03M -65.01M -64.4M -65.99M -71.19M -76.25M -71.97M -71.56M -66.27M
Net Income
-54.25M -76.57M -69.92M -76.7M -77.09M -74.39M -71.97M -75.57M -72.79M -69.97M -70.27M -68.68M -70.52M -75.63M -76.25M -71.97M -71.56M -66.27M
Selling & General & Admin
18.4M 22.27M 21.4M 21.43M 22.73M 21.52M 22.12M 21.62M 19.27M 18.49M 17.83M 18.28M 18.94M 18.18M 17.14M 15.98M 15.9M 15.02M
Research & Development
37.54M 47.59M 54.04M 62.79M 68.69M 70.83M 73.7M 79.08M 78.97M 84.22M 84.41M 81.9M 78.14M 70.59M 65.5M 59.6M 55.37M 50.44M
Other Expenses
18.63M 18.84M 6.34M 4.36M 596K 385K 478K 2.5M 2.51M 2.71M 2.64M -702K -470K -242K n/a 1.81M 1.86M 1.92M
Operating Expenses
74.56M 88.49M 81.39M 88.19M 91.62M 92.55M 96.02M 100.91M 98.25M 102.72M 102.24M 98.85M 96.2M 88.33M 82.64M 77.39M 73.12M 67.37M
Interest Expense
115K 121K 137K 151K 168K 305K 459K 724K 1.11M 1.42M 1.73M 1.98M 2.31M 2.59M 2.86M 3.09M 3.41M 3.74M
Selling & Marketing Expenses
n/a -356K -711K -1.07M -1.07M -714K -359K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
83.53M 97.81M 82.1M 89.26M 92.69M 93.27M 96.38M 100.91M 98.25M 102.72M 102.24M 98.85M 96.2M 88.33M 82.64M 77.39M 73.12M 67.37M
Income Tax Expense
n/a n/a n/a 1.07M 1.07M 1.25M 369K 274K 30K -58K 5.26M 4.28M 4.53M 4.44M n/a n/a n/a n/a
Shares Outstanding (Basic)
191.55M 190.71M 185.61M 189M 188.04M 175.63M 168.44M 167.51M 166.06M 161.64M 154.42M 151M 148.75M 143.32M 101.29M 101.02M 96.87M 93.43M
Shares Outstanding (Diluted)
192.4M 190.71M 189.96M 189M 188.04M 175.63M 168.44M 167.51M 166.06M 161.64M 154.42M 151M 148.75M 148.43M 101.29M 101.29M 96.87M 93.43M
EPS (Basic)
-0.28 -0.41 -0.38 -0.42 -0.44 -0.43 -0.43 -0.47 -0.46 -0.45 -0.47 -0.53 -0.61 -0.71 -0.78 -0.75 -0.8 -0.8
EPS (Diluted)
-0.28 -0.41 -0.38 -0.42 -0.44 -0.43 -0.43 -0.47 -0.46 -0.45 -0.47 -0.53 -0.61 -0.71 -0.78 -0.75 -0.8 -0.8
EBITDA
-53.12M -75.09M -68.4M -75.14M -75.48M -72.66M -70.99M -73.39M -70.5M -67.25M -61.86M -60.88M -62.03M -66.89M -71.64M -67.06M -66.3M -60.6M
EBIT
-54.14M -76.45M -69.78M -76.55M -76.92M -74.08M -72.39M -74.75M -71.83M -68.61M -63.29M -62.42M -63.68M -68.6M -73.39M -68.87M -65.61M -59.98M
Depreciation & Amortization
1.01M 1.36M 1.38M 1.41M 1.44M 1.43M 1.4M 1.35M 1.33M 1.37M 1.43M 1.55M 1.65M 1.7M 1.75M 1.81M 1.86M 1.92M